Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.7650
0.00 (0.00%)
Oct 1, 2026, 4:10 PM AEST
Orthocell Market Cap
Orthocell has a market cap or net worth of 208.33 million as of October 1, 2026. Its market cap has decreased by -40.60% in one year.
Market Cap
208.33M
Enterprise Value
165.35M
Revenue
11.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.77
ChartMarket Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 208.33M, an increase of 601.46%. That is a compound annual growth rate of 17.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 208.33M | -29.23% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 412.00M |
| Starpharma Holdings | 391.02M |
| Racura Oncology | 378.41M |
| Tetratherix | 316.23M |
| BLS Pharmaceuticals | 233.76M |
| Actinogen Medical | 223.18M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 141.09M |